APA (7th ed.) Citation
Dlouhy, I., Armengol, M. A., Recasens-Zorzo, C., Ribeiro, M. L., Pérez-Galán, P., Bosch Albareda, F., . . . Roué, G. (2021). Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation.
Chicago Style (17th ed.) Citation
Dlouhy, Ivan, Marc Antoni|||0000-0001-5206-9139 Armengol, Clara Recasens-Zorzo, Marcelo L.|||0000-0003-4529-7832 Ribeiro, Patricia|||0000-0003-3895-5024 Pérez-Galán, Francesc|||0000-0001-9241-2886 Bosch Albareda, Armando|||0000-0002-8588-8381 López Guillermo, and Gaël|||0000-0003-0245-2257 Roué. Interleukin-1 Receptor Associated Kinase 1/4 and Bromodomain and Extra-terminal Inhibitions Converge on NF-κB Blockade and Display Synergistic Antitumoral Activity in Activated B-cell Subset of Diffuse Large B-cell Lymphoma with MYD88 L265P Mutation. 2021.
MLA (9th ed.) Citation
Dlouhy, Ivan, et al. Interleukin-1 Receptor Associated Kinase 1/4 and Bromodomain and Extra-terminal Inhibitions Converge on NF-κB Blockade and Display Synergistic Antitumoral Activity in Activated B-cell Subset of Diffuse Large B-cell Lymphoma with MYD88 L265P Mutation. 2021.
Warning: These citations may not always be 100% accurate.